table of content
1 Introduction to Research & Analysis Reports
1.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Overall Market Size
2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players in Global Market
3.2 Top Global Gastrointestinal Stromal Tumor Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gastrointestinal Stromal Tumor Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastrointestinal Stromal Tumor Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
7 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies Profiles
7.1 Yin Feng Gene
7.1.1 Yin Feng Gene Company Summary
7.1.2 Yin Feng Gene Business Overview
7.1.3 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.1.4 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Yin Feng Gene Key News & Latest Developments
7.2 KingMed
7.2.1 KingMed Company Summary
7.2.2 KingMed Business Overview
7.2.3 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.2.4 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 KingMed Key News & Latest Developments
7.3 Geneis
7.3.1 Geneis Company Summary
7.3.2 Geneis Business Overview
7.3.3 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.3.4 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Geneis Key News & Latest Developments
7.4 Haplox
7.4.1 Haplox Company Summary
7.4.2 Haplox Business Overview
7.4.3 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.4.4 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Haplox Key News & Latest Developments
7.5 AmoyDX
7.5.1 AmoyDX Company Summary
7.5.2 AmoyDX Business Overview
7.5.3 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.5.4 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 AmoyDX Key News & Latest Developments
7.6 Admera
7.6.1 Admera Company Summary
7.6.2 Admera Business Overview
7.6.3 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.6.4 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Admera Key News & Latest Developments
7.7 GeneChem
7.7.1 GeneChem Company Summary
7.7.2 GeneChem Business Overview
7.7.3 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.7.4 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 GeneChem Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
